Antonin Schmitt

884 total citations
48 papers, 557 citations indexed

About

Antonin Schmitt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Antonin Schmitt has authored 48 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Antonin Schmitt's work include Colorectal Cancer Treatments and Studies (13 papers), Neutropenia and Cancer Infections (11 papers) and Cancer Treatment and Pharmacology (10 papers). Antonin Schmitt is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Neutropenia and Cancer Infections (11 papers) and Cancer Treatment and Pharmacology (10 papers). Antonin Schmitt collaborates with scholars based in France, Switzerland and United Kingdom. Antonin Schmitt's co-authors include Bernard Royer, Étienne Chatelut, Françoise Goirand, François Ghiringhelli, Julie Vincent, Leïla Bengrine-Lefèvre, Jean-Christophe Boyer, Maëva Wendremaire, Boris Guiu and Mathieu Boulin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Hepatology.

In The Last Decade

Antonin Schmitt

44 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonin Schmitt France	15	274	208	118	76	57	48	557
Devron R. Shah United Kingdom	7	241 0.9×	190 0.9×	187 1.6×	37 0.5×	48 0.8×	8	599
Yiqun Zhang United States	17	346 1.3×	288 1.4×	138 1.2×	32 0.4×	38 0.7×	36	805
Joline S.W. Lind Netherlands	14	276 1.0×	184 0.9×	315 2.7×	46 0.6×	32 0.6×	20	656
London Lucien Ooi Singapore	12	354 1.3×	231 1.1×	136 1.2×	87 1.1×	27 0.5×	21	719
Rajendra Pradhan United States	14	131 0.5×	200 1.0×	121 1.0×	47 0.6×	105 1.8×	33	795
Xin Cai China	14	288 1.1×	120 0.6×	103 0.9×	37 0.5×	19 0.3×	39	638
Michela Guardascione Italy	16	336 1.2×	331 1.6×	195 1.7×	61 0.8×	80 1.4×	37	847
Federica Rascio Italy	13	152 0.6×	318 1.5×	137 1.2×	33 0.4×	22 0.4×	20	802
Yi Ling Teo Singapore	9	262 1.0×	228 1.1×	130 1.1×	26 0.3×	57 1.0×	11	625

Countries citing papers authored by Antonin Schmitt

Since Specialization

Citations

This map shows the geographic impact of Antonin Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonin Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonin Schmitt more than expected).

Fields of papers citing papers by Antonin Schmitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonin Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonin Schmitt. The network helps show where Antonin Schmitt may publish in the future.

Co-authorship network of co-authors of Antonin Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of Antonin Schmitt. A scholar is included among the top collaborators of Antonin Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonin Schmitt. Antonin Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmitt, Antonin, et al.. (2025). Impact of gastrectomy on cabozantinib exposure: Clinical case of a patient with clear renal cell carcinoma. Clinical Genitourinary Cancer. 23(5). 102396–102396.

Ghiringhelli, François, et al.. (2024). Plasma clearance of 5-fluorouracil is more influenced by variations in glomerular filtration rate than by uracil concentration. Cancer Chemotherapy and Pharmacology. 95(1). 9–9. 2 indexed citations

Schmitt, Antonin, et al.. (2024). The harms of inappropriate digoxin prescribing in cancer patients: A drug-drug interaction with posaconazole. Annales Pharmaceutiques Françaises. 82(5). 762–764.

Puszkiel, Alicja, Eva Pereira, Audrey Bellesœur, et al.. (2024). Improving olaparib exposure to optimize adverse effects management. Therapeutic Advances in Medical Oncology. 16. 12693064–12693064. 1 indexed citations

Schmitt, Antonin, et al.. (2023). Case report: 5-Fluorouracil treatment in patient with an important partial DPD deficiency. Frontiers in Oncology. 13. 1187052–1187052. 2 indexed citations

Royer, Bernard, Courèche Kaderbhaï, & Antonin Schmitt. (2023). Pharmacokinetics and Pharmacodynamic of Alpelisib. Clinical Pharmacokinetics. 62(1). 45–53. 7 indexed citations

Launay, Manon, Bernard Royer, Jérôme Guitton, et al.. (2022). Quantitative impact of pre‐analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. British Journal of Clinical Pharmacology. 89(2). 762–772. 15 indexed citations

Perron, Valérie, et al.. (2022). Smartphone-based application and nurses’ interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center. Journal of Oncology Pharmacy Practice. 32(2). 278–286. 1 indexed citations

Khan, Amira Sayed, Aziz Hichami, Babar Murtaza, et al.. (2022). Novel Fat Taste Receptor Agonists Curtail Progressive Weight Gain in Obese Male Mice. Cellular and Molecular Gastroenterology and Hepatology. 15(3). 633–663. 10 indexed citations

10.

Selle, Frédèric, Jean‐Jacques Boffa, Gabriel Étienne, et al.. (2022). Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI. Bulletin du Cancer. 109(12). 1245–1261.

11.

Thomas, Fabienne, Manon Launay, Camille Tron, et al.. (2021). Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation. Annals of Oncology. 32(6). 810–811. 11 indexed citations

12.

Schmitt, Antonin, L. Uwer, Véronique Lorgis, et al.. (2021). 1707P A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin. Annals of Oncology. 32. S1189–S1189.

13.

Étienne-Grimaldi, Marie-Christine, Fabienne Thomas, Florence Dalenc, et al.. (2021). Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients. Cancer Chemotherapy and Pharmacology. 87(2). 229–239. 6 indexed citations

14.

Royer, Bernard, Antonin Schmitt, Thierry Nguyen, et al.. (2020). Exposure‐response analysis of Raltitrexed assessing liver toxicity. British Journal of Clinical Pharmacology. 87(3). 1327–1337. 4 indexed citations

15.

Hadi, Tarik, Christophe Ramseyer, Thomas Gautier, et al.. (2020). Lipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages. JCI Insight. 5(24). 7 indexed citations

16.

Vincent, Julie, Valérie Quipourt, Sophie Marilier, et al.. (2019). Therapeutic drug monitoring as a tool to optimize 5-FU–based chemotherapy in gastrointestinal cancer patients older than 75 years. European Journal of Cancer. 111. 116–125. 19 indexed citations

17.

Laffont, Céline M., et al.. (2013). Model-Based Approach to Describe G-CSF Effects in Carboplatin-Treated Cancer Patients. Pharmaceutical Research. 30(11). 2795–2807. 18 indexed citations

18.

Juric, Dejan, Jordi Rodón, Howard A. Burris, et al.. (2012). BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study. Cancer Research. 72. 29 indexed citations

19.

Rubie, Hervé, Birgit Geoerger, Didier Frappaz, et al.. (2010). Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. European Journal of Cancer. 46(15). 2763–2770. 15 indexed citations

20.

Schmitt, Antonin, et al.. (2005). 113 Improving Aerosol Drug Delivery in CF therapy. Journal of Cystic Fibrosis. 4. S31–S31. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact